Literature DB >> 19197072

Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood.

Gregory B Pott1, Edward D Chan, Charles A Dinarello, Leland Shapiro.   

Abstract

Several observations suggest endogenous suppressors of inflammatory mediators are present in human blood. alpha-1-Antitrypsin (AAT) is the most abundant serine protease inhibitor in blood, and AAT possesses anti-inflammatory activity in vitro and in vivo. Here, we show that in vitro stimulation of whole blood from persons with a genetic AAT deficiency resulted in enhanced cytokine production compared with blood from healthy subjects. Using whole blood from healthy subjects, dilution of blood with RPMI tissue-culture medium, followed by incubation for 18 h, increased spontaneous production of IL-8, TNF-alpha, IL-1 beta, and IL-1R antagonist (IL-1Ra) significantly, compared with undiluted blood. Dilution-induced cytokine production suggested the presence of one or more circulating inhibitors of cytokine synthesis present in blood. Serially diluting blood with tissue-culture medium in the presence of cytokine stimulation with heat-killed Staphylococcus epidermidis (S. epi) resulted in 1.2- to 55-fold increases in cytokine production compared with S. epi stimulation alone. Diluting blood with autologous plasma did not increase the production of IL-8, TNF-alpha, IL-1 beta, or IL-1Ra, suggesting that the endogenous, inhibitory activity of blood resided in plasma. In whole blood, diluted and stimulated with S. epi, exogenous AAT inhibited IL-8, IL-6, TNF-alpha, and IL-1 beta significantly but did not suppress induction of the anti-inflammatory cytokines IL-1Ra and IL-10. These ex vivo and in vitro observations suggest that endogenous AAT in blood contributes to the suppression of proinflammatory cytokine synthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197072      PMCID: PMC2669404          DOI: 10.1189/jlb.0208145

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  52 in total

Review 1.  Innate immunity and inflammation: a transcriptional paradigm.

Authors:  J Hawiger
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  How T-lymphocytes are activated and become activators by cell-cell interaction.

Authors:  J M Dayer
Journal:  Eur Respir J Suppl       Date:  2003-09

3.  Regulation of Staphylococcus epidermidis-induced IFN-gamma in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF.

Authors:  Rogier J L Stuyt; Soo-Hyun Kim; Leonid L Reznikov; Giamila Fantuzzi; Daniela Novick; Menachem Rubinstein; Bart Jan Kullberg; Jos W M van der Meer; Charles A Dinarello; Mihai G Netea
Journal:  Cytokine       Date:  2003-01-21       Impact factor: 3.861

Review 4.  alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.

Authors:  R W Carrell
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

5.  Cell surface protease activity of human lymphocytes; its inhibition by alpha 1-antitrypsin.

Authors:  J Bata; J P Martin; J P Revillard
Journal:  Experientia       Date:  1981-05-15

Review 6.  Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

Authors:  Frederick J de Serres
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

7.  Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways.

Authors:  K Dabbagh; G J Laurent; A Shock; P Leoni; J Papakrivopoulou; R C Chambers
Journal:  J Cell Physiol       Date:  2001-01       Impact factor: 6.384

8.  C-terminal fragment of alpha1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor.

Authors:  S Janciauskiene; F Moraga; S Lindgren
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

9.  Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

Authors:  L Shapiro; G B Pott; A H Ralston
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

Review 10.  Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.

Authors:  Keiko Ozato; Hideki Tsujimura; Tomohiko Tamura
Journal:  Biotechniques       Date:  2002-10       Impact factor: 1.993

View more
  79 in total

1.  Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.

Authors:  Sabine Geiger; Emrah I Ozay; Ulf Geumann; Marina K Hereth; Terese Magnusson; Sudarvili Shanthalingam; Daniela Hirsch; Stefanie Kälin; Christine Günther; Barbara A Osborne; Gregory N Tew; Felix G Hermann; Lisa M Minter
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

2.  Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Stefan F Ehrentraut; Mark E Gerich; Eóin N McNamee; Martine C McManus; Matthew D P Lebsack; Paul Jedlicka; Tania Azam; Edwin F de Zoeten; Charles A Dinarello; Jesús Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

Review 3.  Immune-modulating effects of alpha-1 antitrypsin.

Authors:  Mario R Ehlers
Journal:  Biol Chem       Date:  2014-10       Impact factor: 3.915

Review 4.  Targeting Innate Immunity for Type 1 Diabetes Prevention.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

5.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

6.  Alpha-1-antitrypsin phenotypes and neutrophil elastase gene promoter polymorphisms in lung cancer.

Authors:  Aleksandra Topic; Mila Ljujic; Aleksandra Nikolic; Natasa Petrovic-Stanojevic; Vesna Dopudja-Pantic; Marija Mitic-Milikic; Dragica Radojkovic
Journal:  Pathol Oncol Res       Date:  2010-06-03       Impact factor: 3.201

7.  α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.

Authors:  Jingjing Wang; Zhen Sun; Wenyu Gou; David B Adams; Wanxing Cui; Katherine A Morgan; Charlie Strange; Hongjun Wang
Journal:  Diabetes       Date:  2017-01-09       Impact factor: 9.461

8.  α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.

Authors:  Peter A Gottlieb; Aimon K Alkanani; Aaron W Michels; Eli C Lewis; Leland Shapiro; Charles A Dinarello; Danny Zipris
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

9.  α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

Authors:  Angelia D Lockett; Samuel Kimani; Godfrey Ddungu; Sabine Wrenger; Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

10.  A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression.

Authors:  Adam Burgener; Annelie Tjernlund; Tove Kaldensjo; Max Abou; Stuart McCorrister; Garrett R Westmacott; Kenzie Mogk; Emma Ambrose; Kristina Broliden; Blake Ball
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.